Announcement • Apr 22
Autonomous Guard Ltd to Report Q4, 2025 Results on Apr 27, 2026 Autonomous Guard Ltd announced that they will report Q4, 2025 results on Apr 27, 2026 Announcement • Apr 03
Autonomous Guard Ltd, Annual General Meeting, May 10, 2026 Autonomous Guard Ltd, Annual General Meeting, May 10, 2026. Location: barnea law offices, Israel New Risk • Mar 19
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$17m free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-US$4.6m). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (211% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (₪110.6m market cap, or US$35.4m). New Risk • Mar 16
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$17m free cash flow). Share price has been highly volatile over the past 3 months (12% average weekly change). Negative equity (-US$4.6m). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (211% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (₪98.4m market cap, or US$31.6m). New Risk • Nov 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$17m free cash flow). Negative equity (-US$4.6m). Earnings have declined by 60% per year over the past 5 years. Shareholders have been substantially diluted in the past year (211% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Market cap is less than US$100m (₪105.7m market cap, or US$32.3m). New Risk • Sep 01
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$17m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$17m free cash flow). Negative equity (-US$4.6m). Earnings have declined by 59% per year over the past 5 years. Shareholders have been substantially diluted in the past year (209% increase in shares outstanding). Revenue is less than US$1m. Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₪141.7m market cap, or US$42.2m). New Risk • Jul 02
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 200% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 27% per year over the past 5 years. Shareholders have been substantially diluted in the past year (200% increase in shares outstanding). Revenue is less than US$1m (US$232k revenue). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₪122.6m market cap, or US$36.4m). New Risk • Jun 14
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₪36.0m (US$9.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 27% per year over the past 5 years. Revenue is less than US$1m (US$232k revenue). Market cap is less than US$10m (₪36.0m market cap, or US$9.93m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. New Risk • Apr 01
New major risk - Revenue and earnings growth Earnings have declined by 27% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 27% per year over the past 5 years. Revenue is less than US$1m (US$232k revenue). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₪37.1m market cap, or US$10.0m). New Risk • Feb 08
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue is less than US$1m (US$427k revenue). Market cap is less than US$10m (₪32.1m market cap, or US$9.00m). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Valuation Update With 7 Day Price Move • Oct 01
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₪10.07, the stock trades at a trailing P/E ratio of 65.3x. Average trailing P/E is 10x in the Capital Markets industry in Israel. Total loss to shareholders of 25% over the past three years. New Risk • May 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Israeli stocks, typically moving 8.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (US$67k revenue). Market cap is less than US$10m (₪19.3m market cap, or US$5.20m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. New Risk • Mar 19
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (US$67k revenue). Market cap is less than US$10m (₪18.6m market cap, or US$5.09m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (5.8% average weekly change). Shareholders have been diluted in the past year (21% increase in shares outstanding). New Risk • Mar 18
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 38% per year over the past 5 years. Revenue is less than US$1m (US$67k revenue). Market cap is less than US$10m (₪18.5m market cap, or US$5.07m). Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (21% increase in shares outstanding). Announcement • Nov 24
TechnoPlus Ventures Ltd., Annual General Meeting, Jan 02, 2024 TechnoPlus Ventures Ltd., Annual General Meeting, Jan 02, 2024, at 12:00 Israel Standard Time. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. 3 independent directors (5 non-independent directors). Independent Director Julia Levy was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 2 independent directors (5 non-independent directors). Independent Director Gili Cohen was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 31
Full year 2021 earnings released: EPS: US$0.058 (vs US$0.38 loss in FY 2020) Full year 2021 results: EPS: US$0.058 (up from US$0.38 loss in FY 2020). Revenue: US$667.0k (up 152% from FY 2020). Net income: US$105.0k (up US$792.0k from FY 2020). Profit margin: 16% (up from net loss in FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 58 percentage points per year, which is a significant difference in performance. Reported Earnings • Mar 27
Full year 2020 earnings released: US$0.38 loss per share (vs US$0.64 profit in FY 2019) Full year 2020 results: Net loss: US$687.0k (down 160% from profit in FY 2019). Over the last 3 years on average, earnings per share has increased by 72% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment improved over the past week After last week's 16% share price gain to US$30.00, the stock is trading at a trailing P/E ratio of 27.6x, up from the previous P/E ratio of 23.8x. This compares to an average P/E of 22x in the Capital Markets industry in Israel. Total returns to shareholders over the past three years are 117%. Is New 90 Day High Low • Feb 11
New 90-day high: ₪28.79 The company is up 106% from its price of ₪13.97 on 12 November 2020. The Israeli market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 14% over the same period. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 20% share price gain to US$25.45, the stock is trading at a trailing P/E ratio of 23.4x, up from the previous P/E ratio of 19.4x. This compares to an average P/E of 20x in the Capital Markets industry in Israel. Total returns to shareholders over the past three years are 44%. Is New 90 Day High Low • Jan 21
New 90-day high: ₪25.45 The company is up 81% from its price of ₪14.07 on 22 October 2020. The Israeli market is up 26% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 18% over the same period. Valuation Update With 7 Day Price Move • Jan 11
Investor sentiment improved over the past week After last week's 16% share price gain to US$23.00, the stock is trading at a trailing P/E ratio of 21.7x, up from the previous P/E ratio of 18.6x. This compares to an average P/E of 20x in the Capital Markets industry in Israel. Total returns to shareholders over the past three years are 33%. Is New 90 Day High Low • Jan 08
New 90-day high: ₪2.12 The company is up 31% from its price of ₪1.62 on 08 October 2020. The Israeli market is up 21% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 11% over the same period. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 45% share price gain to US$2.05, the stock is trading at a trailing P/E ratio of 19.1x, up from the previous P/E ratio of 13.2x. This compares to an average P/E of 16x in the Capital Markets industry in Israel. Total returns to shareholders over the past three years are 27%. Is New 90 Day High Low • Dec 28
New 90-day high: ₪2.05 The company is up 31% from its price of ₪1.56 on 29 September 2020. The Israeli market is up 26% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 19% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: ₪1.27 The company is down 19% from its price of ₪1.57 on 08 September 2020. The Israeli market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 8.0% over the same period. Is New 90 Day High Low • Oct 29
New 90-day low: ₪1.32 The company is down 15% from its price of ₪1.55 on 29 July 2020. The Israeli market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 9.0% over the same period.